Wells Vehicle Electronics since Apr 2007
President
Pylon Manufacturing Corporation 2004 - 2007
President
Visteon 1997 - 2003
Vice President/General Manager-Global Aftermarket Operations
Tenneco 1977 - 1997
Vice President-Sales and Marketing
Education:
Northwestern University - Kellogg School of Management 1991 - 1991
Advanced Executive Degree
York University - Schulich School of Business 1979 - 1981
MBA, Finance and Marketing
Cornell University 1971 - 1975
BA, Economics
Skills:
Mergers & Acquisitions Leadership Automotive Aftermarket Marketing Lean Manufacturing Business Planning Market Analysis Automotive Negotiation Competitive Analysis Pricing Product Development Six Sigma Contract Negotiation Strategic Planning Sales Team Building Purchasing Sales Operations Manufacturing Product Management P&L Management Coaching Forecasting Supply Chain Management Inventory Management Business Strategy Income Statement New Business Development Project Management Kaizen Continuous Improvement Cross-functional Team Leadership Vehicles Customer Service Retail Sales Management Microsoft Excel Process Improvement Customer Satisfaction SPC Profit Electronics Microsoft Office Team Leadership Product Marketing Business Development International Business Product Design Operations Management
University Of Illinois Oncology 1801 W Taylor St STE 1E, Chicago, IL 60612 3123551625 (phone), 3123551515 (fax)
Education:
Medical School University of Pittsburgh School of Medicine Graduated: 1980
Procedures:
Bone Marrow Biopsy Chemotherapy Bone Marrow or Stem Cell Transplant
Conditions:
Hodgkin's Lymphoma Leukemia Lung Cancer Multiple Myeloma Non-Hodgkin's Lymphoma
Languages:
English Spanish
Description:
Dr. Peace graduated from the University of Pittsburgh School of Medicine in 1980. He works in Chicago, IL and specializes in Hematology/Oncology. Dr. Peace is affiliated with University Of Illinois Hospital Health & Science Center.
Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes formed between the protein expression product and antibodies in body fluid, allows the diagnosis of the presence of a malignancy. The present invention also discloses methods and compositions for treating a malignancy.
Immune Reactivity To Expressed Activated Oncogenes For Diagnosis And Treatment Of Malignancy
Martin Cheever - Mercer Island WA, US David Peace - Chicago IL, US
Assignee:
Washington Research Foundation - Seattle WA
International Classification:
C12Q001/68 G01N033/574
US Classification:
435/007230, 435/006000
Abstract:
Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes formed between the protein expression product and antibodies in body fluid, allows the diagnosis of the presence of a malignancy. The present invention also discloses methods and compositions for treating a malignancy.
Immune Reactivity To Expressed Activated Oncogenes For Diagnosis And Treatment Of Malignancy
Martin A. Cheever - Mercer Island WA David J. Peace - Seattle WA
Assignee:
Washington Research Foundation - Seattle WA
International Classification:
C12Q 102 G01N 33574
US Classification:
435 723
Abstract:
Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes formed between the protein expression product and antibodies in body fluid, allows the diagnosis of the presence of a malignancy. The present invention also discloses methods and compositions for treating a malignancy.
Immune Reactivity To Expressed Activated Oncogenes For Diagnosis And Treatment Of Malignancy
Martin A. Cheever - Mercer Island WA David J. Peace - Seattle WA
Assignee:
Washington Research Foundation - Seattle WA
International Classification:
G01N 3353 G01N 33574
US Classification:
435 723
Abstract:
Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes formed between the protein expression product and antibodies in body fluid, allows the diagnosis of the presence of a malignancy. The present invention also discloses methods and compositions for treating a malignancy.
Immune Reactivity To Expressed Activated Oncogenes For Diagnosis Of Malignancy
Martin A. Cheever - Mercer Island WA David J. Peace - Seattle WA
Assignee:
Washington Research Foundation - Seattle WA
International Classification:
C07K 300 C12Q 100 C12N 500 A01N 6300
US Classification:
435 29
Abstract:
Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes formed between the protein expression product and antibodies in body fluid, allows the diagnosis of the presence of a malignancy. The present invention also discloses methods and compositions for treating a malignancy.